Free Trial
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel Free RCKTW Stock Alerts

Rocket Pharmaceuticals (RCKTW) Competitors

Rocket Pharmaceuticals logo
$0.0084 +0.00 (+9.10%)
As of 06/8/2026 03:05 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

RCKTW vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy Rocket Pharmaceuticals stock or one of its competitors? MarketBeat compares Rocket Pharmaceuticals with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Rocket Pharmaceuticals include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Rocket Pharmaceuticals compare to Ainos?

Rocket Pharmaceuticals (NASDAQ:RCKTW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, analyst recommendations, valuation, media sentiment, institutional ownership and profitability.

In the previous week, Rocket Pharmaceuticals and Rocket Pharmaceuticals both had 1 articles in the media. Rocket Pharmaceuticals' average media sentiment score of 0.59 beat Ainos' score of 0.49 indicating that Rocket Pharmaceuticals is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rocket Pharmaceuticals
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Ainos
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company Net Margins Return on Equity Return on Assets
Rocket PharmaceuticalsN/A N/A N/A
Ainos N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rocket PharmaceuticalsN/AN/AN/AN/AN/A
Ainos$18.11KN/AN/AN/AN/A

Summary

Rocket Pharmaceuticals and Ainos tied by winning 1 of the 2 factors compared between the two stocks.

How does Rocket Pharmaceuticals compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Rocket Pharmaceuticals (NASDAQ:RCKTW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends and media sentiment.

In the previous week, Rocket Pharmaceuticals had 1 more articles in the media than Alvotech. MarketBeat recorded 1 mentions for Rocket Pharmaceuticals and 0 mentions for Alvotech. Rocket Pharmaceuticals' average media sentiment score of 0.59 beat Alvotech's score of 0.00 indicating that Rocket Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Alvotech Neutral
Rocket Pharmaceuticals Positive

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Rocket Pharmaceuticals N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$586.32MN/AN/AN/AN/A
Rocket PharmaceuticalsN/AN/AN/AN/AN/A

Summary

Rocket Pharmaceuticals beats Alvotech on 2 of the 3 factors compared between the two stocks.

How does Rocket Pharmaceuticals compare to Aravive?

Rocket Pharmaceuticals (NASDAQ:RCKTW) and Aravive (NASDAQ:ARAV) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rocket PharmaceuticalsN/AN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

Company Net Margins Return on Equity Return on Assets
Rocket PharmaceuticalsN/A N/A N/A
Aravive N/A N/A N/A

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Rocket Pharmaceuticals had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for Rocket Pharmaceuticals and 0 mentions for Aravive. Rocket Pharmaceuticals' average media sentiment score of 0.59 beat Aravive's score of 0.00 indicating that Rocket Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
Rocket Pharmaceuticals Positive
Aravive Neutral

Summary

Rocket Pharmaceuticals and Aravive tied by winning 2 of the 4 factors compared between the two stocks.

How does Rocket Pharmaceuticals compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Rocket Pharmaceuticals (NASDAQ:RCKTW) are both pharmaceutical products companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, media sentiment, valuation and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. IIN/A N/A N/A
Rocket Pharmaceuticals N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A
Rocket PharmaceuticalsN/AN/AN/AN/AN/A

In the previous week, Rocket Pharmaceuticals had 1 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 1 mentions for Rocket Pharmaceuticals and 0 mentions for Atlantic Coastal Acquisition Corp. II. Rocket Pharmaceuticals' average media sentiment score of 0.59 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that Rocket Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
Rocket Pharmaceuticals Positive

Summary

Rocket Pharmaceuticals beats Atlantic Coastal Acquisition Corp. II on 2 of the 2 factors compared between the two stocks.

How does Rocket Pharmaceuticals compare to Biofrontera?

Rocket Pharmaceuticals (NASDAQ:RCKTW) and Biofrontera (NASDAQ:BFRIW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, media sentiment, dividends, analyst recommendations and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rocket PharmaceuticalsN/AN/AN/AN/AN/A
Biofrontera$43.20MN/AN/AN/AN/A

In the previous week, Rocket Pharmaceuticals had 1 more articles in the media than Biofrontera. MarketBeat recorded 1 mentions for Rocket Pharmaceuticals and 0 mentions for Biofrontera. Rocket Pharmaceuticals' average media sentiment score of 0.59 beat Biofrontera's score of 0.00 indicating that Rocket Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
Rocket Pharmaceuticals Positive
Biofrontera Neutral

Company Net Margins Return on Equity Return on Assets
Rocket PharmaceuticalsN/A N/A N/A
Biofrontera N/A N/A N/A

Summary

Rocket Pharmaceuticals beats Biofrontera on 2 of the 3 factors compared between the two stocks.

Get Rocket Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for RCKTW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RCKTW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RCKTW vs. The Competition

Export
MetricRocket PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$435.24M$6.48B$11.99B
Dividend YieldN/A3.86%2.67%5.58%
P/E RatioN/A3.2023.6923.74
Price / SalesN/A6,555.73514.83109.27
Price / CashN/A13.1326.9937.25
Price / BookN/A86.7610.436.78
Net IncomeN/A-$96.07M$3.57B$337.51M
7 Day PerformanceN/A-1.43%0.27%-2.34%
1 Month PerformanceN/A0.83%3.25%1.88%
1 Year PerformanceN/A54.21%22.24%25.55%

Rocket Pharmaceuticals Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RCKTW
Rocket Pharmaceuticals
N/A$0.01
+9.1%		N/A-76.1%$0.00N/AN/A240
AIMDW
Ainos
N/A$0.13
-0.3%		N/A+23.2%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.26
flat		N/A-88.1%$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:RCKTW) was last updated on 6/9/2026 by MarketBeat.com Staff.
From Our Partners
June 12: $100 Turns Into $100,000?
The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel